While KRAS and P53 are known prognostic factors in pancreatic cancer survival, the prognostic value of GNAS in iIPMN merits further discussion: Gaujoux et al. found GNAS mutations to be associated with improved survival in 31 cases of resected invasive IPMNs [17]. Here, KRAS is linked to familial pancreatic carcinoma.